Basics iTeos Therapeutics, Inc. IPO Date: June 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $394.6M Activated in VL: True Average Daily Range Avg Daily Range: $0.56 | 2.76% Avg Daily Range (30 D): $0.06 | 0.61% Avg Daily Range (90 D): $0.17 | 2.32% Institutional Daily Volume Avg Daily Volume: .34M Avg Daily Volume (30 D): 1.15M Avg Daily Volume (90 D): 1.15M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 126 Avg Trade Size (Sh.) (90 D): 117 Institutional Trades Total Inst.Trades: 1,116 Avg Inst. Trade: $1.98M Avg Inst. Trade (30 D): $1.25M Avg Inst. Trade (90 D): $1.71M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.95M Avg Closing Trade (30 D): $1.3M Avg Closing Trade (90 D): $1.17M Avg Closing Volume: 96.09K     News Jul 22, 2025 @ 12:39 AM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Jul 21, 2025 @ 7:59 PM $HAREHOLDER ALERT: The M&A Class Action Firm Annou... Source: Juan Monteverde Jul 21, 2025 @ 11:29 AM iTeos Therapeutics Enters into Agreement to Be Acq... Source: Globe Newswire Apr 29, 2025 @ 9:47 PM iTeos publie les résultats financiers de son pr... Source: N/A Apr 29, 2025 @ 9:47 PM iTeos meldet Finanzergebnisse für das erste Qua... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.8 $-1.03 $-3.32 Diluted EPS $-.8 $-1.03 $-3.32 Revenue $ M $ M $ 35M Gross Profit $ $ $ Net Income / Loss $ -34.61M $ -43.71M $ -134.41M Operating Income / Loss $ -40.02M $ -49.33M $ -159.53M Cost of Revenue $ $ $ Net Cash Flow $ 13.96M $ 19.4M $ -107.09M PE Ratio